Long-term outcome in neuroZika: When biological diagnosis matters

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 8PM EDT 4 min · 25 Sep 2026 · NPR News Now

112. H. Foley, Kevin Ryan, Mike Figs | Destruction 1h 40m · 25 Sep 2026 · Story Warz

NPR News: 09-24-2026 7PM EDT 4 min · 24 Sep 2026 · NPR News Now

Montreal Canadiens Play-by-Play Victor Findlay (9/24/26) 17 min · 24 Sep 2026 · Oilers NOW with Bob Stauffer

Could Tom Beat 100 8-Year-Olds? 22 min · 24 Sep 2026 · Wolf & Owl with Romesh Ranganathan and Tom Davis

BITESIZE | The Truth About Stress: How to Reduce Overwhelm & Feel Calmer Every Day | Dr Rangan Chatterjee #682 26 min · 24 Sep 2026 · Feel Better, Live More with Dr Rangan Chatterjee

Report any issue

Source

Recorded20 May 2019

Publisherneurology.libsyn.com ↗

Handlerec:5447929

Show notes

In the first segment, Dr. Stacey Clardy talks with Dr. Annie Lannuzel about the importance of biological diagnosis in long-term outcome in neuroZika. In the second part of the podcast, Dr. Will Rondeau focuses his interview with Dr. Stuart Connolly on his NEJM paper on the full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. The paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051. CME Opportunity: Listen to this week's Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in